As the need to draw awareness to cervical, ovarian, uterine/endometrial, vaginal, and vulvar cancer becomes more evident, ...

New reserach has identified particular genetic mutations that elevate the risk of breast and ovarian cancers, aiding in ...

1 in 75 women develop ovarian cancer in their lifetime and Everyone with ovaries is at risk ...

From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in ...

Researchers developed a pan-immune-inflammation–based nomogram to accurately predict overall survival (OS) and ...

Dr. Diego Aviles with UT Physicians says symptoms of ovarian cancer typically include bloating, pain in the stomach or pelvis ...

Adding a PD-1 inhibitor to PARP inhibitor maintenance therapy failed to slow progression or improve survival in newly ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Johnson & Johnson (JNJ) announced that its subsidiary, Red River Talc LLC, has voluntarily filed for a prepackaged Chapter 11 ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

Ovarian cancer is a type of cancer that impacts the female reproductive system. The risk of developing ovarian cancer in a woman's lifetime is 1 in 87, according to the American Cancer Society (ACS).

The past 15 months have been challenging regarding treatment for my ovarian cancer. But today, my goal is to focus on healing ...